The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
A Brief Overview of the WHO Classification of Breast Tumors, 4th Edition, Focusing on Issues and Updates from the 3rd Edition
Open accessAbstract
The WHO Classification of Tumors of the Breast, 4th edition, is an update to the 3rd edition that was published in 2003, and covers all neoplastic and preneoplastic lesions of the breast. Changes to the 4th edition include new aspects and changes to the terminology that reflect our present-day knowledge of these lesions. Definitions for histopathological diagnosis are complemented by a description of clinical features, epidemiology, macroscopy, genetics, and prognostic and predictive features. In this review of the WHO classification, we have focused on invasive carcinomas, precursor lesions, and some benign epithelial proliferations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Goldhirsch, A., Wood, W. C., Coates, A. S., Gelber, R. D., Thürlimann, B., & Senn, H.-J. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr304 · Cited by 3,836
Pathology and Genetics of Tumours of the Breast and Female Genital Organs
Tavassoli, F. A., & Devilee, P. (2003) · International Agency for Research on Cancer eBooks · Cited by 2,800
Cuzick, J., Sestak, I., Baum, M., Buzdar, A., Howell, A., Dowsett, M., & Forbes, J. F. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70257-6 · Cited by 1,674
WHO classification of tumours of the breast
Lakhani, S. R., Ellis, I. O., Schnitt, S. J., Tan, P. H., & van de Vijver, M. J. (2012) · International Agency for Research on Cancer eBooks · Cited by 1,524
当科におけるせき髄しゅよう術後の長期経過観察 術後せき柱変形について
Shidahara, S., Marui, S., Akiyama, T., & Wakita, Y. (1982) · Orthopedics & Traumatology · doi:10.5035/nishiseisai.30.715 · Cited by 1,299
Atypical hyperplastic lesions of the female breast. A long-term follow-up study
Page, D. L., Dupont, W. D., Rogers, L. W., & Rados, M. S. (1985) · Cancer · doi:10.1002/1097-0142(19850601)55:11<2698::aid-cncr2820551127>3.0.co;2-a · Cited by 961
Burstein, H. J., Prestrud, A. A., Seidenfeld, J., Anderson, H., Buchholz, T. A., Davidson, N. E., Gelmon, K. E., Giordano, S. H., Hudis, C. A., Malin, J., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.3756 · Cited by 796
Adherence to Therapy With Oral Antineoplastic Agents
Partridge, A. H. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.9.652 · Cited by 584
Weigelt, B., Horlings, H., Kreike, B., Hayes, M., Hauptmann, M., Wessels, L., de Jong, D., Van de Vijver, M., Veer, L. V., & Peterse, J. (2008) · The Journal of Pathology · doi:10.1002/path.2407 · Cited by 562
Adherence to Initial Adjuvant Anastrozole Therapy Among Women With Early-Stage Breast Cancer
Partridge, A. H., LaFountain, A., Mayer, E., Taylor, B. S., Winer, E., & Asnis-Alibozek, A. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.5451 · Cited by 482
Niemeier, L. A., Dabbs, D. J., Beriwal, S., Striebel, J. M., & Bhargava, R. (2010) · Modern Pathology · doi:10.1038/modpathol.2009.159 · Cited by 401
A clinically relevant gene signature in triple negative and basal-like breast cancer
Rody, A., Karn, T., Liedtke, C., Pusztai, L., Ruckhaeberle, E., Hanker, L., Gaetje, R., Solbach, C., Ahr, A., Metzler, D., et al. (2011) · Breast Cancer Research · doi:10.1186/bcr3035 · Cited by 338
Mandelblatt, J. S., Hadley, J., Kerner, J. F., Schulman, K. A., Gold, K., Dunmore-Griffith, J., Edge, S., Guadagnoli, E., Lynch, J. J., Meropol, N. J., et al. (2000) · Cancer · doi:10.1002/1097-0142(20000801)89:3<561::aid-cncr11>3.0.co;2-a · Cited by 277
Fitzgibbons, P. L., Henson, D. E., & Hutter, R. V. P. (1998) · PubMed · Cited by 276
Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer
Ziller, V., Kalder, M., Albert, U.-S., Holzhauer, W., Ziller, M., Wagner, U., & Hadji, P. (2009) · Annals of Oncology · doi:10.1093/annonc/mdn646 · Cited by 263
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Aebi, S., Davidson, T., Gruber, G., & Cardoso, F. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr371 · Cited by 256
Consensus conference on the classification of ductal carcinoma in Situ
Rosser, R. J. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980601)82:11<2293::aid-cncr29>3.0.co;2-o · Cited by 210
van de Water, W., Markopoulos, C., van de Velde, C. J. H., Seynaeve, C., Hasenburg, A., Rea, D., Putter, H., Nortier, J. W. R., de Craen, A. J. M., Hille, E. T. M., et al. (2012) · JAMA · doi:10.1001/jama.2012.84 · Cited by 200
Wetterskog, D., Lopez‐Garcia, M. A., Lambros, M. B., A'Hern, R., Geyer, F. C., Milanezi, F., Cabral, M. C., Natrajan, R., Gauthier, A., Shiu, K., et al. (2012) · The Journal of Pathology · doi:10.1002/path.2974 · Cited by 169
Lacroix‐Triki, M., Suarez, P. H., MacKay, A., Lambros, M. B., Natrajan, R., Savage, K., Geyer, F. C., Weigelt, B., Ashworth, A., & Reis‐Filho, J. S. (2010) · The Journal of Pathology · doi:10.1002/path.2763 · Cited by 162
Improving compliance and persistence to adjuvant tamoxifen and aromatase inhibitor therapy
Hadji, P. (2009) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2009.02.001 · Cited by 152
Nold, R. J., Beamer, R. L., Helmer, S. D., & McBoyle, M. F. (2000) · The American Journal of Surgery · doi:10.1016/s0002-9610(00)00501-8 · Cited by 146
Noncompliance with adjuvant radiation, chemotherapy, or hormonal therapy in breast cancer patients
Ma, A. M. T., Barone, J., Wallis, A. E., Wu, N. J., Garcia, L. B., Estabrook, A., Rosenbaum-Smith, S. M., & Tartter, P. I. (2008) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2008.06.027 · Cited by 115
Breast core needle biopsy: issues and controversies
Bilous, M. (2010) · Modern Pathology · doi:10.1038/modpathol.2010.34 · Cited by 73
Valldeoriola, F., Coronell, C., Pont‐Sunyer, C., Buongiorno, M., Cámara, A., Gaig, C., Compta, Y., & on behalf of the members of the ADHESON Study Group (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03320.x · Cited by 68
Wengström, Y., Aapro, M., di Priolo, S. L., Cannon, H., & Georgiou, V. (2007) · The Breast · doi:10.1016/j.breast.2007.02.007 · Cited by 50
Primary breast cancer therapy in six regions of Germany
Engel, J., Nagel, G., Breuer, E., Meisner, C., Albert, U. ‐., Strelocke, K., Sauer, H., Katenkamp, D., Mittermayer, C., Heidemann, E., et al. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00407-5 · Cited by 44
van Nes, J. G. H., Seynaeve, C., Jones, S., Markopoulos, C. J., Putter, H., & van de Velde, C. J. �. (2010) · British journal of surgery · doi:10.1002/bjs.6962 · Cited by 29
Duration of adjuvant endocrine therapy of breast cancer: how much is enough?
Ward, J. H. (2009) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0b013e328334ff40 · Cited by 16
Cited by
Breast Cancer and the Other Non-Coding RNAs
Dvorská, D., Braný, D., Ňachajová, M., Halašová, E., & Danková, Z. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063280 · Cited by 38
Metadata
- Authors
- Sinn, H.-P., & Kreipe, H.
- Venue
- Breast Care
- Publisher
- S. Karger AG
- Published
- 2013
- Volume
- 8
- Issue
- 2
- Pages
- 149-154
- ISSN
- 1661-3791 (ISSN-L)
- 1661-3805
- OpenAlex
- W2053174388
- Cited by
- 403
- References
- 31
- FWCI
- 9.78
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.